Document is current
Any future updates will be listed below
-
Authors
Nemergut, Michal
Marques, Sérgio M.
Uhrik, Lukas
Vanova, Tereza
Nezvedova, Marketa
Gadara, Darshak Chandulal
Jha, Durga
Tulis, Jan
Novakova, Veronika
Planas-Iglesias, Joan
Kunka, Antonin
Legrand, Anthony
Hribkova, Hana
Pospisilova, Veronika
Sedmik, Jiri
Raska, Jan
Prokop, Zbynek
Damborsky, Jiri
Bohaciakova, Dasa
Spacil, Zdenek
Hernychova, Lenka
Bednar, David
Marek, Martin https://orcid.org/0000-0001-7220-5644
-
Funding
Funding for this research was provided by:
Grantová Agentura České Republiky (22-09853S)
European Union’s Horizon Europe (101087124)
- License Information
-
More Information
Article History
Received: 6 November 2022
Accepted: 19 April 2023
First Online: 6 June 2023
Declarations
:
: Not applicable.
: All authors have approved of the consents of this manuscript and provided consent for publication.
: JD and ZP are founders of the biotechnology spin-off company Enantis Ltd. The company is not involved in R&D in the domain of Alzheimer’s Disease.
: Not applicable.
